What is ALBO's gross margin?

Albireo Pharma (ALBO) has a gross margin of 94% and a net margin of -391%.

What is ALBO's P/E ratio?

Track Albireo Pharma (ALBO) P/E ratio, ROE, and valuation metrics over time.

Where can I see ALBO's full financials?

See Albireo Pharma (ALBO) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

Albireo Pharma (ALBO) Financials — Revenue, Earnings, Cash Flow

$44.15

Last traded 2023-03-02 — delisted

NASDAQ · Healthcare · Biotechnology · $915.9M mcap · 14M float · 4.16% daily turnover

Overview News Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Dividends Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest

📊 Key Metrics

TTM

$57M

Revenue

+432.7% YoY

$-137M

Net Income

-187.0% YoY

$-117M

Free Cash Flow

+4.5% YoY

93.8%

Gross Margin

-352.5%

Op. Margin

-390.7%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-97.5%

ROA-44.5%

ROIC79.3%

Valuation

P/E-5.6

P/B4.8

EV/EBITDA-1.5

Leverage

Debt/Equity0.00

Current Ratio6.32

Interest Cov.-9.8x

Quality Scores

Piotroski F4/9

Altman Z-1.02

Beneish M-0.73